Originator Organization PrecisemAb Biotech Co., LtdStartup |
Active Organization PrecisemAb Biotech Co., LtdStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | PrecisemAb Biotech Co., LtdStartup | 13 Sep 2024 |